Helmerich & Payne Reports Q1 FY2026 Net Loss Driven by Impairment, Highlights Operational Strength & Debt Reduction
Summary
Helmerich & Payne reported a Q1 FY2026 net loss of $(97) million, or $(0.98) per share, impacted by a $103 million impairment charge, but highlighted adjusted earnings of $(14) million, strong operational performance, and significant debt repayment.
Key Events
-
Reports Q1 FY2026 Financial Results
The company announced its financial results for the first fiscal quarter ended December 31, 2025.
-
Consolidated Net Loss Due to Impairment
Reported a consolidated net loss of $(97) million, or $(0.98) per share, which includes a non-cash impairment charge of $103 million.
-
Adjusted Earnings Show Smaller Loss
Adjusted earnings, excluding the impairment and other non-recurring items, were $(14) million, or $(0.15) per share.
-
Strong Operational Performance and Technology Adoption
North America Solutions (NAS) reported strong direct margins and successfully deployed FlexRobotics™ Technology, with increasing technology adoption across its active fleet. International Solutions also showed improved operating results.
Analysis
Helmerich & Payne reported a consolidated net loss for its first fiscal quarter, primarily due to a substantial non-cash impairment charge. While the GAAP net loss was significant, adjusted earnings showed a smaller loss, reflecting underlying operational performance. The North America Solutions segment demonstrated strong direct margins and successful deployment of new technology, while the International Solutions segment showed improved results and ongoing rig reactivations. The company also made significant progress in debt reduction, repaying a substantial portion of its term loan ahead of schedule. This mixed financial picture, with a notable one-time charge offset by operational strength and balance sheet improvement, provides a nuanced view for investors.
At the time of this filing, HP was trading at $36.70 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $14.65 to $36.73. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.